BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36592073)

  • 1. Severe and Moderate Primary Graft Dysfunction in Adult Heart Recipients.
    Stefen SP; Tenório DF; Cirillo GCG; Gaspar SF; Oliveira KAS; Gaiotto FA; Jatene FB
    Braz J Cardiovasc Surg; 2023 Apr; 38(2):214-218. PubMed ID: 36592073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation.
    Squiers JJ; DiMaio JM; Van Zyl J; Lima B; Gonzalez-Stawisnksi G; Rafael AE; Meyer DM; Hall SA
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1178-1183. PubMed ID: 34100537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.
    Ayer A; Truby LK; Schroder JN; Casalinova S; Green CL; Bishawi MA; Bryner BS; Milano CA; Patel CB; Devore AD
    J Card Fail; 2023 Jan; 29(1):67-75. PubMed ID: 36351494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.
    Seguchi O; Fujita T; Murata Y; Sunami H; Sato T; Watanabe T; Nakajima S; Kuroda K; Hisamatsu E; Sato T; Yanase M; Hata H; Wada K; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Heart Vessels; 2016 Apr; 31(4):555-62. PubMed ID: 25682298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of primary graft dysfunction after heart transplantation.
    Settepani F; Pedrazzini GL; Olivieri GM; Merlanti B; Cannata A; Lanfranconi M; Frigerio M; Russo CF
    J Card Surg; 2022 May; 37(5):1290-1298. PubMed ID: 35229361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
    Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation.
    Foroutan F; Alba AC; Stein M; Krakovsky J; Chien KGW; Chih S; Guyatt G; Ross H
    J Heart Lung Transplant; 2019 Mar; 38(3):260-266. PubMed ID: 30642796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Power Output Index and Severe Primary Graft Dysfunction After Heart Transplantation.
    Lim HS; Ranasinghe A; Chue C; Quinn D; Mukadam M; Mascaro J
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):398-403. PubMed ID: 32747204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Recipient Thyroid Hormone Supplementation in Primary Graft Dysfunction After Heart Transplantation: A Propensity-Adjusted Analysis.
    Gosling AF; Wright MC; Cherry A; Milano CA; Patel CB; Schroder JN; DeVore A; McCartney S; Kerr D; Bryner B; Podgoreanu M; Nicoara A
    J Cardiothorac Vasc Anesth; 2023 Nov; 37(11):2236-2243. PubMed ID: 37586950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor thyroid hormone therapy is associated with an increased risk of graft dysfunction after heart transplantation.
    Peled Y; Lavee J; Kassif Y; Arad M; Kogan A; Peled A; Tirosh A; Sternik L; Ram E
    Clin Transplant; 2020 Jul; 34(7):e13887. PubMed ID: 32367594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation.
    Han J; Rushakoff J; Moayedi Y; Henricksen E; Lee R; Luikart H; Shalakhti O; Gragert L; Benck L; Malinoski D; Kobashigawa J; Teuteberg J; Khush KK; Patel J; Kransdorf E
    J Heart Lung Transplant; 2024 Mar; 43(3):387-393. PubMed ID: 37802261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.